- Home
- UNB vs CRDL Comparison
UNB vs CRDL Comparison
Compare UNB & CRDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UNB
- CRDL
- Stock Information
- Founded
- UNB 1891
- CRDL 2017
- Country
- UNB United States
- CRDL Canada
- Employees
- UNB N/A
- CRDL N/A
- Industry
- UNB Major Banks
- CRDL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- UNB Finance
- CRDL Health Care
- Exchange
- UNB Nasdaq
- CRDL Nasdaq
- Market Cap
- UNB 99.3M
- CRDL 97.3M
- IPO Year
- UNB 1998
- CRDL N/A
- Fundamental
- Price
- UNB $22.99
- CRDL $1.03
- Analyst Decision
- UNB
- CRDL Strong Buy
- Analyst Count
- UNB 0
- CRDL 2
- Target Price
- UNB N/A
- CRDL $9.00
- AVG Volume (30 Days)
- UNB 11.1K
- CRDL 401.1K
- Earning Date
- UNB 11-10-2025
- CRDL 11-13-2025
- Dividend Yield
- UNB 6.21%
- CRDL N/A
- EPS Growth
- UNB 27.30
- CRDL N/A
- EPS
- UNB 2.47
- CRDL N/A
- Revenue
- UNB $52,533,000.00
- CRDL N/A
- Revenue This Year
- UNB N/A
- CRDL N/A
- Revenue Next Year
- UNB N/A
- CRDL N/A
- P/E Ratio
- UNB $9.40
- CRDL N/A
- Revenue Growth
- UNB 13.25
- CRDL N/A
- 52 Week Low
- UNB $20.65
- CRDL $0.77
- 52 Week High
- UNB $37.70
- CRDL $1.67
- Technical
- Relative Strength Index (RSI)
- UNB 48.98
- CRDL 47.21
- Support Level
- UNB $21.50
- CRDL $0.94
- Resistance Level
- UNB $23.33
- CRDL $1.05
- Average True Range (ATR)
- UNB 0.72
- CRDL 0.06
- MACD
- UNB 0.09
- CRDL -0.00
- Stochastic Oscillator
- UNB 80.17
- CRDL 56.67
About UNB Union Bankshares Inc.
Union Bankshares Inc operates as a community bank in the financial services industry. It offers retail and commercial banking services to its customers through its branches, ATMs, telebanking, and internet banking systems. The company provides retail banking services to individuals and commercial banking services to small and medium-sized corporations, partnerships, and sole proprietorships, as well as nonprofit organizations, local municipalities, and school districts within its market area. In addition, it also offers fiduciary and asset management services through its Asset Management Group.
About CRDL Cardiol Therapeutics Inc.
Cardiol Therapeutics Inc is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart diseases. The company's main product candidate, CardiolRx, is a pharmaceutically manufactured oral cannabidiol formulation that is being clinically developed for use in heart diseases. Cardiol has received Investigational New Drug Application authorization from the United States Food and Drug Administration to conduct clinical studies to evaluate the efficacy and safety of CardiolRx in two diseases affecting the heart which are a Phase II multi-national trial, the ARCHER trial, in acute myocarditis; and a Phase II multi-center open-label pilot study in recurrent pericarditis.